¡u¬ì¾Çªº­«ÂI¨Ã«D½ÆÂøªº¼Æ¾Ç¤½¦¡©ÎªÌ¬YºØ§Î¦¡ªº¹êÅç¡C¬ì¾Çªº®Ö¤ß¬O¤@ºØ±Ó¾Uªº¸Û¹êºA«×, ¥Øªº´N¬O­nª¾¹D¦³¤°»ò¨Æ±¡¥¿¦bµo¥Í¡C¡v  
 
--------- ª«²z¾Ç®a ¨F®Ô£»«Où ¥v¯Ç
 
 
  «Ü¦h¤H¹ï¶Ê¯v·P¨ì¯«¯¦¡A¬Æ­P¤j³¡¤À¤H¹ï¶Ê¯vªº²z¸Ñ³£¥u¬O¶Ê¯v®v¤â¤W´¤µÛ¤@­ÓÄÁÂ\¡AµM«á§i¶D¹ï¤è«Ü§Ö«K·|¶i¤J¶Ê¯vª¬ºA¡C¨Æ¹ê¤W¡A·í¤µªºµ´¤j¦h¼Æ¶Ê¯vªvÀø®v¤w¸g¤£¦A¨Ï¥Î³oºØ¹L®Éªº§Þ³N¤F¡C«Ü¦h¤£¤F¸Ñ¶Ê¯vªº¤H³£·|°Ý , ¶Ê¯v¬O§_¯uªº¯à°÷±a¨Ó¹ê½èªº§ïÅÜ , §í©Î¥u¬O¦Û´Û´Û¤H ? §A­Ì³£«H¿à¬ì¾Ç¡A»{¬°¬ì¾Ç¨ã¦³«ÈÆ[©Ê¡C ¬JµM¦p¦¹ , §Ú­Ì´N°Ñ¦Ò¤@¨Ç¦³Ãö¶Ê¯vªºªñ¥N¬ì¾Ç¬ã¨s§a¡C¨Æ¹ê¤W¡A±q¤W¤@­Ó¥@¬ö¤¤¨ì¥»¥@¬ö³o¤@¬q®É¶¡¤§¤º¡A¤j¶q¤ß²z¾Ç®a¡BÂå¥Í¡B¯«¸g¬ì¾Ç®a´¿¸g°µ¹L¤j¤j¤p¤p¦UºØ¤£¦Pªº¶Ê¯v¹êÅç¡C¥H¤U¦CÁ|¤F¨ä¤¤¤@¤p³¡¤À¥H§@°Ñ¦Ò :

¬ü°ê¤@¥÷¾Ç³N´Á¥Z ¡§Journal of Consulting and Clinical Psychology¡¨´¿³ø¾É¬ü°ê«X¥è«X¦{¥ß¤j¾Ç¥Ñ¤T¦ì±M®a²Õ¦¨ªº¬ã¨s¤p²Õ¦³Ãö¶Ê¯v¯à°÷´£¤É¨­Åé§K¬Ì¯à¤Oªº¬ã¨s³ø§i¡C³o¤T¦ì±M®a¥]¬A¤ß²z¤Îºë¯«¯f¾Ç±Ð±Â Janice Kiecolt Glaserl, ¤ú©P¯f¾Ç±Ð±Â Phillip Marucha, ¥H¤Î¤À¤l¯f¬r¾Ç±Ð±Â Ronald Glaser¡C¥L­Ì´¿¥H33¦ìÂå¬ì¤Î¤ú¬ì¾Ç¥Í§@¬°¬ã¨s¹ï¹³¡C 33¦ì¾Ç¥Í³Q¤À¬°¨â²Õ¡CA²Õ¾Ç¥Í³Q±Ð±Â¦Û§Ú¶Ê¯v§Þ¥©, ¨Ã¦b·Ç³Æ¾Ç´Á¦Ò¸Õªº°ªÀ£®É¶¡¸g±`½m²ß¦Û§Ú¶Ê¯v¡CB²Õ¾Ç¥Í¬O¹ï·Ó²Õ, ¨Ã¨S¦³±Ð±Â¦Û§Ú¶Ê¯v¡C¦b¨â²Õ¾Ç¥Í¦Ò¸Õ¶}©l«e¤T¤é¨C²Õ©â¨ú¦å²G¼Ë¥»¤ÆÅç¡Cµ²ªG, A²Õ¾Ç¥ÍªºT ¥Õ¦å²Ó­M¬¡ÅD²v(¥Î¥H¶q«×§K¬Ì¤Oªº«ü¼Ð)¥­§¡¤W¤É¤F8%, ¦ÓB²Õ«h¥­§¡¤U­°¤F33%¡C¥t¥~, ¬ã¨s¥çµo²{·U¸g±`½m²ß¶Ê¯v§Þ¥©ªº¾Ç¥Í, ¥L­Ìªº§K¬Ì¤ÏÀ³·U¦n¡C (Janice Kiecolt Glaserl Journal of Consulting and Clinical Psychology)

³o­Ó¬ã¨sÅã¥Ü , ·í¤Hªø´Á¨­³BÀ£¤OªºÀô¹Ò, §K¬Ì¤O·|¤U­°¡C¶Ê¯v¤£¦ý¯à°÷´î»´À£¤O, ¦Ó¥B¯à°÷¦³®Ä´£¤É¨­Åé§K¬Ì¾÷¯à¡C¦]¦¹, ¹ï©ó¥Í¬¡ºò±iªº³£¥«¤H¨Ó»¡, ¶Ê¯v¬O¥­¿Å¨­¤ß¨t²Îªº¦³®Ä¤u¨ã¡C

¦b¥t¤@­Ó¦³Ãö¶Ê¯vªº¬ã¨s¤¤ (Olness, MacDonald, and Uden 1987) ¡A 28 ¦ì¦~ÄÖ¤¶¥G 6-12 ·³±w¦³°¾ÀYµhªº¨àµ£³Q¦w±Æ§@¬°¹êÅç¹ï¶H¡C¥L­Ì³QÀH¾÷¦w±Æ¬Y¨Ç¤£¦PªºªvÀø±¡ªp¤¤¡C¨ä¤¤¤@ºØ»Ý­nªA¥Î¯à°÷ªvÀø¯U¤ß¯g¡B­ìµo©Ê°ª¦åÀ£¥H¤Î°¾ÀYµhµ¥ªº‰xª«¤ß±o¦w (Propranolol) ¡C¥t¤@ºØ¥u¬O±µ¨ü¦w¼¢¾¯®ÄÀ³ (Placebo Effect) ªvÀøµ¥¡C¥L­Ì»Ý­n±µ¨ü¤j¬ù¤C­Ó¤ëªºªvÀø¡C¤C­Ó¤ë¤§«á¡A©Ò¦³¨àµ£³Q±Ð±Â¦Û§Ú¶Ê¯v§Þ¥©¡A³sÁZ¶i¦æ¤T­Ó¤ë¡C³o¨Ç§Þ¥©¥]¬A¶Ê¯v©ñÃP¡B·Q¹³¶}¤ß´r§Öªº´º¹³¥H¤Îµh·¡±±¨îµ¥¡C³o­Ó¬ã¨sªºµ²ªGÅã¥Ü¡A¸g¹L¦Û§Ú¶Ê¯vªº°V½m»P¤Î½m²ß¤§«á¡A°¾ÀYµh¥X²{ªºÀW²v¤j´T¤U­°¡A¥i¬O¦b±µ¨ü¦Û§Ú¶Ê¯v¤§«e¡A¥L­Ìªº¯fúG¨Ã¨S¦³¤Q¤À©úÅ㪺§ï¶i¡C
("Comparison of Self-hypnosis and propranolol in the treatment of juvenile class migraine", Pediatrics, pp. 593-597)

¬ü°ê±KªÛ®Ú¤j¾Ç (University of Michigan) ¤p¨à¬ì¾Ç¨t´¿¸g¤½¶}¤@­Ó¦³Ãö¤p¨à©]§¿ªº¬ã¨s¡C 50 ¦ì¦~ÄÖ¤¶¥G 5 ¡V 16 ·³¸g±`¦b§É¤W©]§¿ªº¨àµ£ (30 ­Ó¨k«Ä 20 ­Ó¤k«Ä ) ³Q¿ï¾Ü¬°¹êÅç¹ï¶H¡C¨ä¤¤¤@²Õ±µ¨üÃĪ«ªvÀø , »Ý­nªA¥Î¤@ºØ¥s°µ imipramine ªºßÓª«¡C Imipramine ¬O¤@ºØ¼W¥[§¿¹Dªý¤O¤Î»H¯Ö®e¿nªºßÓª«¡C¥t¥~¤@²Õ³Q±µ¨ü¶Ê¯v¡C¶Ê¯vªº¤º®e¥]¬A·t¥Ü³o¨Ç¨àµ£ªº¼ç·NÃÑ·í»H¯Ö¤w¸g¥Rº¡¤F§¿²G¡A¥L­Ì«K·|¦Û°ÊºÎ¿ô¡A¨Ã¥B¥h¬~¤â¶¡±Æ§¿µM«á¦A¦¸¦^¨ì§É¤WºÎµÛµ¥¡C ³o­Ó¬ã¨sºû«ù¤F¤E­Ó¤ë , ¥H¤U´N¬O¦³Ãö³o­Ó¬ã¨sªºµ²ªG :

¶Ê¯v¤F²Õ§O

Imipamine ²Õ§O

¥¿­±¤ÏÀ³

¨S¦³¥ô¦ó¤ÏÀ³

¥¿­±¤ÏÀ³

¨S¦³¥ô¦ó¤ÏÀ³

17/25 (68%)

8/25 (32%)

6/25(24%)

19/25(76%)

¡u ¨S¦³¥ô¦ó¤ÏÀ³ ¡v «üªº´N¬O§¿§Éªº±¡úG¨S¦³§ïÅÜ¡C
¡u¥¿­± ¤ÏÀ³ ¡v «üªº´N¬O§¿§Éªº±¡úG§¹¥þ®ø¥¢©ÎªÌ¦¸¼Æ´î§C¡C

±q¥H¤W³o­Ó¬ã¨sµ²ªG¥i¥HÅã¥Ü¡A¶Ê¯v¤ñ°_¶Ç²Î Imipamine ÃĪ«ªº®ÄªG§ó¥[²z·Q¡A¦Ó¥B¨S¦³¥ô¦ó°Æ§@¥Î¡C

¶Ê¯v¹ï©óªvÀø¥Ö½§¯e¯f¥ç¯à°÷Åã¥Ü¬Û·íº¡·Nªº®ÄªG ¡C¦b¥t¤@­ÓªvÀø¬Ð (Wart) ªº¬ã¨s¤¤ , ¥|¤Q¦ì¯f¤H³Q¤À°t¬°¥|­Ó²Õ§O¡C²Ä¤@²Õ§O³Q¦w±Æ±µ¨ü¶Ê¯vªvÀø¡A²Ä¤G­Ó²Õ§O±µ¨ü¶Ç²ÎªºÃĪ«ªvÀø¡A²Ä¤T­Ó²Õ§O¬O¦w¼¢¾¯®ÄÀ³²Õ§O , ²Ä¥|­Ó²Õ§O¨S¦³±µ¨ü¥ô¦óªvÀø¡Cµ²ªGÅã¥Ü¡A¥u¦³²Ä¤@²Õªº¯f¤H¬Ðªº¼Æ¥Ø©úÅã¦a´î¤Ö¡C (Spano, Williams, & Gwynn, M.I. 1990, "Effects of hypnotic, placebo, and salicylic acid treatments on wart regression", Psychosomatic Medicine 52, pp. 109-114. )

¹ï©ó«°¥«¤Hªº¤ß²z±þ¤â§íÆ{¯g (Depression) ¡A¶Ê¯v§ó¥[¬O«Ü¦³®ÄªºªvÀø¨}¤è ¡C´¿¸g¦³¤@­Ó¬ã¨s±w¦³ªø´ÁÃö¸`ª¢µh¯gªº¯f¤H¡A¥L­Ì³£±a¦³µJ¼{¤Î§íÆ{¯gª¬¡C§íÆ{¯g¯f±wªÌ¨­Å餺ªº¤º°ØÊy (Endorphins) §t¶q³£¤ñ¥¿±`¤H§C¡C³o¨Ç¯f¤H¦b±µ¨ü¶Ê¯vªvÀø¤@¬q®É¶¡¤§«á¡A¥L­Ìªº¨­Åéµh·¡¡AµJ¼{¡A¥H¤Î§íÆ{¯gª¬³£¦³Åã¦a´î»´¡C¤£¦ý¦p¦¹¡A¬ã¨sµ²ªGÅã¥Ü¥L­Ì¨­Å餤ªº¤º°ØÊy§t¶q¥ç©úÅã¦a¼W¥[¡C (Domangue, B.B., Margolis, C.G. Lieberman, D. & Kaji, H.(1985), "Biochemical Correlates of Hypnoanalgesia in Arthritic Pain Patients", Journal of Clinical Psychiatry, 46, pp. 235-238.)

¹ï©ó¤@¨Ç¯f±¡®e©ö´_µoªº¯f¤H¨Ó»¡¡A¶Ê¯v¯à°÷À°§U¥L­Ì¦³®Ä±±¨î¯f±¡ ¡C¤T¤Q¦ì±w¦³¤Q¤G«ü¸z¼ìºÅªº¯f¤H³Q¦w±Æ§@¬°¬ã¨s¹ï¶H¡C¥L­Ì³£¦³®e©ö´_µoªº¯f±¡¡C¥L­Ì³Q¤À¦¨¨â²Õ¡C²Ä¤@²Õ¥u±µ¨ü‰xª«ªvÀø¡A²Ä¤G²Õ¦b¤Q¬P´Á¤º³Q¦w±Æ±µ¨üÃĪ«¥H¤Î¶Ê¯vªvÀø¡Cµ²ªGÅã¥Ü¡A©Ò¦³¥u±µ¨üÃĪ«ªvÀøªº¯f¤H³£¦³´_µo¡A¥i¬O²Ä¤G²Õªº¯f¤H·í¤¤¥u¦³¤@¥bªº¯f¤H¥X²{´_µoªº±¡ªp¡C (Colgan, S.M., Faragher, E.B. & Whorwell, P.J.(1988), "Controlled Trail of Hypnotherapy in Relapse Pervention of Duodenal Ulceration", Lancet, 1299-1300)

¶Ê¯v¥ç´¿¸g³Qµý¹ê¹ï©óµÎ½w®ð³Ý¯f (Asthma) ¥ç«D±`¦³®Ä ¡C­^°êÂå¾Ç´Á¥Z (British Medical Journal) ³Q»{¬°¬O­^°êÂå¾Ç¬ÉªºÅv«Â¥Zª«¡C´¿¸g¦³¤@¦¸¤½¶}¤F¤@­Ó¦³Ãö¶Ê¯vªº¬ã¨s¡C³o­Ó¬ã¨sÅã¥Ü¹ï©ó±µ¨ü¶Ê¯vªvÀøªº¯f±wªÌ¨Ó»¡ , ®ð³Ý¯f¥X²{ªºÀW²v¥H¤Î»Ý­nªA¥ÎÃĪ«ªº¾¯¶q¤ñ°_±µ¨ü¶Ç²ÎªvÀøªº¯f¤H¬Û¹ï¸û¤Ö¡C (Maher-Loughnan, G.P., MacDonald, N., Mason, A.A. & Fry, L. (1962), "Controlled Trial of Hypnosis in the Symptomatic Treatment of Asthma". British Medical Journal 2, pp. 371-376.

¦b¥t¤@­Ó ¦³Ãö¶Ê¯v¤îµhªº¬ã¨s ¤¤ , ¤@²Õ±w¦³¨ÅÀù (Breast cancer) ªº¤k¤h±µ¨ü¤@¦~ªº¤p²Õ¶Ê¯vªvÀø¡A³o²Õ¤k¤h¤ñ°_¥t¥~¤@¨Ç¨S¦³±µ¨ü¶Ê¯vªvÀøªº¨ÅÀù¤k¯f¤H¨Ó»¡ , µo²{Àù¯g±aµ¹¦o­Ìªºµh·¡¤U­°¤F 50% ¡C (Spiegel, D. & Bloom, J.R. (1983), "Group therapy and Hypnosis Reduce Metastatic Breast Carcinoma Pain", Psychosomatic Medicine 45, pp. 333-339)

¶Ê¯v¥ç´¿¸g³Q¥Î§@¬ã¨sªvÀø¥¢¯vªº®ÄªG¡Aµ²ªG¥O¤H«D±`¹ª»R ¡C¥|¤Q¤­¦ì´ú¸Õ¹ï¶HÀH¾÷¦a¤À¬°¤T²Õ¡C²Ä¤@²Õ±µ¨ü¶Ê¯vªvÀø¡A²Ä¤G²Õ±µ¨ü¦w¼¢¾¯®ÄÀ³´ú¸Õ , ²Ä¤T²Õ¬O±±¨î²Õ , ¥L­Ì³sÄò±µ¨ü¥|¬P´Á¨C¬P´Á¤T¤Q¤ÀÄÁªºªvÀø¡C²Ä¤@²Õ¯f¤H¶i¤J¶Ê¯vª¬ºA¤§«á³Q¤Þ¾É·Q¹³¥h¤F¤@­Ó«ÜµÎªAªº¯S§Oªº¦a¤è , ¨Ã·t¥Ü¥[±j¥L­Ì¬O§Úªº¤O¶q¡A¨Ï¥L­Ì¯à°÷©ñ¶}¨º¨Ç§xÂZªº°ÝÃD¡C¦w¼¢¾¯®ÄÀ³ªº¤@²Õ¹ï¶H³Q¤Þ¾É·Q¹³¤@¨Ç¤¤¥ßªº¹Ï¹³¡Cµ²ªGÅã¥Ü¥u¦³±µ¨ü¶Ê¯vªvÀøªº¹ï¶H¯à°÷¦³®Ä§ïµ½¥L­ÌªººÎ¯vµ{«×¹F 50% ¡C ( Stanton, H.E. (1989),"Hypnotic relaxation and the reduction of sleep onset insomnia", International Journal of Psychosomatics, 36(1-4, pp. 64-68)

±q¥H¤WºØºØ¬ì¾Ç¬ã¨s¥i¥Hª¾¹D¡A¶Ê¯vªº¦Ó¥B½T¯à°÷±a¨Ó«Ü¦h¹ê½èªºÁ{§É®ÄªG¡A¦Ó¥B¨S¦³¥ô¦ó°Æ§@¥Î¡C¶Ê¯vªvÀø¤w¸g³Q¤½»{¬°¦¨¬°¤Ü¤@¥@¬ö¨ä¤¤¤@ºØ·¥¬°­«­nªºªvÀø¤èªk¡C